Page 9 - CIMA SCS Workbook November 2018 - Day 1 Suggested Solutions
P. 9
SUGGESTED SOLUTIONS
Development of Over The Counter (OTC) drugs that do not require prescription
Threats
Reputational damage can be caused through drug tests having adverse reactions on
volunteers (as witnessed by Horter)
Drug companies can be targeted by action groups protesting against animal testing
Failure to persuade regulatory bodies such as the PRA to sanction government purchase of
drugs on cost/benefit grounds (e.g. Werstra with the drug Denovax)
Millions can be spent on research projects that do not result in a marketable product
Drugs going off-patent open up the market to competition
Quoted companies suffer the possible threat of hostile takeover
Counterfeit drugs i.e. where ‘fake’ drugs are marketed with illegal use of trademarked
name
High costs of litigation in the event of unforeseen/undisclosed side effects (e.g. Johnson &
Johnson fine of US$4.7 billion in damages in July 2018 over claims that talcum powder led
to ovarian cancer)
Failure to recruit skilled scientists will lead to unsuccessful research projects
Poor manufacturing controls can lead to environmental damage e.g. waste product
entering local water systems
KAPLAN PUBLISHING 49